Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2016

27.03.2015 | Case Report

A Rare Case of Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplant Patient

verfasst von: Kamal Kant Sahu, Gaurav Prakash, Alka Khadwal, Subhash Chander Varma, Pankaj Malhotra

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Sonderheft 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Post bone marrow transplant patients are susceptible to atypical infections, especially viral pathogens. The risk increases many folds in cases of allogeneic transplantation, which also receive GVHD prophylaxis. Viral pathogens like cytomegalovirus and herpes are the common ones encountered during follow-up period. However, in recent times there have been reports of a variety of disease manifestations of rare viruses like polyoma virus and adenovirus. These viral infections may play a crucial role in morbidity and mortality in immunocompromised patients. We hereby elaborate the follow-up course of a 36-year-old post allogeneic transplant patient of acute myeloid leukemia who developed adenovirus related haemorrhagic cystitis. Treatment with oral ribavirin lead to dramatic improvement in symptomatology within a week. This cases re-emphasizes the fact that after ruling out the commoner pathogens, it’s of utmost importance to strongly consider the atypical pathogens in such cases.
Literatur
1.
Zurück zum Zitat Brugieres L, Hartmann O, Travagli JP, Benhamou E, Pico JL, Valteau D et al (1989) Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 7(2):194–199PubMed Brugieres L, Hartmann O, Travagli JP, Benhamou E, Pico JL, Valteau D et al (1989) Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 7(2):194–199PubMed
2.
Zurück zum Zitat Seber A, Shu XO, Defor T, Sencer S, Ramsay N (1999) Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 23(1):35–40CrossRefPubMed Seber A, Shu XO, Defor T, Sencer S, Ramsay N (1999) Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 23(1):35–40CrossRefPubMed
3.
Zurück zum Zitat La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV et al (2001) Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 32(6):871–876CrossRefPubMed La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV et al (2001) Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 32(6):871–876CrossRefPubMed
4.
Zurück zum Zitat Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK et al (1999) Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23(3):277–282CrossRefPubMed Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK et al (1999) Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23(3):277–282CrossRefPubMed
5.
Zurück zum Zitat Suparno C, Milligan DW, Moss PA, Mautner V (2004) Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma 45(5):873–885CrossRefPubMed Suparno C, Milligan DW, Moss PA, Mautner V (2004) Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma 45(5):873–885CrossRefPubMed
6.
Zurück zum Zitat Runde V, Ross S, Trenschel R, Lagemann E, Basu O, Renzing-Kohler K et al (2001) Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 28(1):51–57CrossRefPubMed Runde V, Ross S, Trenschel R, Lagemann E, Basu O, Renzing-Kohler K et al (2001) Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 28(1):51–57CrossRefPubMed
7.
Zurück zum Zitat Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV et al (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169(4):775–781CrossRefPubMed Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV et al (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169(4):775–781CrossRefPubMed
8.
Zurück zum Zitat Akiyama H, Kurosu T, Sakashita C, Inoue T, Mori S, Ohashi K et al (2001) Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 32(9):1325–1330CrossRefPubMed Akiyama H, Kurosu T, Sakashita C, Inoue T, Mori S, Ohashi K et al (2001) Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 32(9):1325–1330CrossRefPubMed
9.
Zurück zum Zitat Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C et al (1998) High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 22(9):889–893CrossRefPubMed Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C et al (1998) High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 22(9):889–893CrossRefPubMed
10.
Zurück zum Zitat Thomas AE, Patterson J, Prentice HG, Brenner MK, Ganczakowski M, Hancock JF et al (1987) Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy. Bone Marrow Transplant 1(4):347–355PubMed Thomas AE, Patterson J, Prentice HG, Brenner MK, Ganczakowski M, Hancock JF et al (1987) Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy. Bone Marrow Transplant 1(4):347–355PubMed
11.
Zurück zum Zitat Mori Y, Miyamoto T, Kato K, Kamezaki K, Kuriyama T, Oku S et al (2012) Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 18(3):458–465CrossRefPubMed Mori Y, Miyamoto T, Kato K, Kamezaki K, Kuriyama T, Oku S et al (2012) Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 18(3):458–465CrossRefPubMed
12.
Zurück zum Zitat Kawakami M, Ueda S, Maeda T, Karasuno T, Teshima H, Hiraoka A et al (1997) Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 20(6):485–490CrossRefPubMed Kawakami M, Ueda S, Maeda T, Karasuno T, Teshima H, Hiraoka A et al (1997) Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 20(6):485–490CrossRefPubMed
13.
14.
Zurück zum Zitat Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V et al (2005) Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis 40(1):199–201CrossRefPubMed Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V et al (2005) Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis 40(1):199–201CrossRefPubMed
15.
Zurück zum Zitat Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P et al (2005) In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 10(2):225–229PubMed Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P et al (2005) In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 10(2):225–229PubMed
16.
Zurück zum Zitat Gavin PJ, Katz BZ (2002) Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110(1 Pt 1):e9CrossRefPubMed Gavin PJ, Katz BZ (2002) Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110(1 Pt 1):e9CrossRefPubMed
17.
Zurück zum Zitat Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M et al (2000) Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 25(5):545–548CrossRefPubMed Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M et al (2000) Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 25(5):545–548CrossRefPubMed
18.
Zurück zum Zitat Cassano WF (1991) Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 7(3):247–248PubMed Cassano WF (1991) Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 7(3):247–248PubMed
19.
Zurück zum Zitat Lakhani A, Raptis A, Frame D, Simpson D, Berkahn L, Mellon-Reppen S et al (1999) Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplant 24(11):1259–1260CrossRefPubMed Lakhani A, Raptis A, Frame D, Simpson D, Berkahn L, Mellon-Reppen S et al (1999) Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplant 24(11):1259–1260CrossRefPubMed
20.
Zurück zum Zitat Laszlo D, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Lombardini L et al (1995) Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Haematologica 80(5):421–425PubMed Laszlo D, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Lombardini L et al (1995) Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Haematologica 80(5):421–425PubMed
Metadaten
Titel
A Rare Case of Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplant Patient
verfasst von
Kamal Kant Sahu
Gaurav Prakash
Alka Khadwal
Subhash Chander Varma
Pankaj Malhotra
Publikationsdatum
27.03.2015
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe Sonderheft 1/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0530-5

Weitere Artikel der Sonderheft 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.